A number of factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker testing market.
The Cardiac
Marker Testing Market is expected to reach $
3.50 Billion by 2021, at a CAGR of 8.8% from 2016 to 2021.
Ask
for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64885447
Market
Segmentation:-
Based on type, the global cardiac marker testing market is
divided into six segments, namely, troponin I and T, CK-MB, BNP or NT-proBNP,
Myoglobin, hsCRP, and other biomarkers. The other biomarkers segment includes
galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and
homocysteine.
On the basis of product, the global cardiac marker market
is segmented into reagents and kits and instruments. The instruments section is
further segmented on the basis of method, namely, chemiluminescence,
immunofluorescence, ELISA, and immunochromatography. On the basis of disease,
the cardiac marker market is segmented into myocardial infarction and
congestive heart failure. On the basis of type of testing, the cardiac marker
testing market is segmented into laboratory testing and point-of-care testing.
Key Market Drivers:-
1 Growing Incidences of
Cardiovascular Diseases
2 Rapidly Increasing Geriatric Population
and the Subsequent Increase in the Burden of Heart Diseases Worldwide
3 Growing Funding From Public–Private
Organizations for Research on Cardiac Biomarkers
4 Ongoing Clinical Trials for
Identification of Novel Cardiac Biomarkers
Regional
Analysis:-
As of 2016, North America held the largest share of the
global cardiac marker market, followed by Europe. However, the Asia-Pacific
market is expected to register the highest CAGR of 11.7% from 2016 to 2021.
Request
for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=64885447
Key
Market Players:-
Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories
(U.S.), Siemens AG (Germany), Danaher Corporation (U.S.) Alere, Inc. (U.S.),
bioMérieux SA (France), LSI Medience Corporation (a subsidiary of Mitsubishi
Chemical Holdings Corporation, Japan), Ortho Clinical Diagnostics (a subsidiary
of The Carlyle Group, U.S.), Randox laboratories Ltd (U.K.), and Guangzhou
Wondfo Biotech Co., Ltd. (Wondfo) (China) are some of the key players operating
in the global cardiac marker testing market.
No comments:
Post a Comment